These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29908515)

  • 1. An altered state? Emergent changes to illicit drug markets and distribution networks in scotland.
    Densley J; McLean R; Deuchar R; Harding S
    Int J Drug Policy; 2018 Aug; 58():113-120. PubMed ID: 29908515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ethnographic exploration of drug markets in Kisumu, Kenya.
    Syvertsen JL; Ohaga S; Agot K; Dimova M; Guise A; Rhodes T; Wagner KD
    Int J Drug Policy; 2016 Apr; 30():82-90. PubMed ID: 26838470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working County Lines: Child Criminal Exploitation and Illicit Drug Dealing in Glasgow and Merseyside.
    Robinson G; McLean R; Densley J
    Int J Offender Ther Comp Criminol; 2019 Apr; 63(5):694-711. PubMed ID: 30338710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
    Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
    Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-drug trafficking: Estimating the scale, trends and harms at the Australian border.
    Hughes CE; Chalmers J; Bright DA; McFadden M
    Int J Drug Policy; 2016 May; 31():80-9. PubMed ID: 26860325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for a risky business: How drug dealers manage customers, suppliers and competitors in Italy, Slovenia and Germany.
    Tzvetkova M; Pardal M; Disley E; Rena A; Talic S; Forberger S
    Int J Drug Policy; 2016 May; 31():90-8. PubMed ID: 27161385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy.
    Boivin R
    Int J Drug Policy; 2014 Mar; 25(2):235-43. PubMed ID: 24418633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.
    Gilbert M; Dasgupta N
    Int J Drug Policy; 2017 Aug; 46():160-167. PubMed ID: 28735772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the structure and operation of drug supply chains: The case of cocaine and heroin in Italy and Slovenia.
    Caulkins JP; Disley E; Tzvetkova M; Pardal M; Shah H; Zhang X
    Int J Drug Policy; 2016 May; 31():64-73. PubMed ID: 26997542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
    Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
    Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crime displacement in digital drug markets.
    Ladegaard I
    Int J Drug Policy; 2019 Jan; 63():113-121. PubMed ID: 30572247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.